NEW YORK (GenomeWeb News) – NanoString Technologies and BD segment BD Biosciences today announced a collaboration to develop a single-cell isolation and analysis workflow.

The two firms will jointly develop a workflow using NanoString's nCounter Analysis System, including the nCounter Single Cell Assay, and the BD Flow Cytometry cell sorter product line, with an emphasis on the new BD FACSJazz cell sorting system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.